188 related articles for article (PubMed ID: 17999771)
1. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells.
Staab A; Loeffler J; Said HM; Diehlmann D; Katzer A; Beyer M; Fleischer M; Schwab F; Baier K; Einsele H; Flentje M; Vordermark D
BMC Cancer; 2007 Nov; 7():213. PubMed ID: 17999771
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D
BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.
Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H
Tumori; 2015; 101(5):578-84. PubMed ID: 26350185
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro.
Staab A; Fleischer M; Loeffler J; Said HM; Katzer A; Plathow C; Einsele H; Flentje M; Vordermark D
Strahlenther Onkol; 2011 Apr; 187(4):252-9. PubMed ID: 21437769
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
6. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
[TBL] [Abstract][Full Text] [Related]
7. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway.
Kung AL; Zabludoff SD; France DS; Freedman SJ; Tanner EA; Vieira A; Cornell-Kennon S; Lee J; Wang B; Wang J; Memmert K; Naegeli HU; Petersen F; Eck MJ; Bair KW; Wood AW; Livingston DM
Cancer Cell; 2004 Jul; 6(1):33-43. PubMed ID: 15261140
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia Triggers Osteochondrogenic Differentiation of Vascular Smooth Muscle Cells in an HIF-1 (Hypoxia-Inducible Factor 1)-Dependent and Reactive Oxygen Species-Dependent Manner.
Balogh E; Tóth A; Méhes G; Trencsényi G; Paragh G; Jeney V
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1088-1099. PubMed ID: 31070451
[TBL] [Abstract][Full Text] [Related]
9. Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1α-neuropilin-1 axis.
Misra RM; Bajaj MS; Kale VP
PLoS One; 2012; 7(11):e50153. PubMed ID: 23185562
[TBL] [Abstract][Full Text] [Related]
10. [Development of a novel screening assay for inhibitors targeting HIF-1alpha and P300 interaction].
Lai FF; Niu F; Yang HZ; Zhou WQ; Chen XG
Yao Xue Xue Bao; 2014 Jun; 49(6):849-53. PubMed ID: 25212031
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
12. Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma.
Viziteu E; Grandmougin C; Goldschmidt H; Seckinger A; Hose D; Klein B; Moreaux J
Br J Cancer; 2016 Mar; 114(5):519-23. PubMed ID: 26867162
[TBL] [Abstract][Full Text] [Related]
13. Modulation of glucose metabolism inhibits hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha).
Staab A; Löffler J; Said HM; Katzer A; Beyer M; Polat B; Einsele H; Flentje M; Vordermark D
Strahlenther Onkol; 2007 Jul; 183(7):366-73. PubMed ID: 17609869
[TBL] [Abstract][Full Text] [Related]
14. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
15. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
16. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
17. Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.
Cook KM; Hilton ST; Mecinovic J; Motherwell WB; Figg WD; Schofield CJ
J Biol Chem; 2009 Sep; 284(39):26831-8. PubMed ID: 19589782
[TBL] [Abstract][Full Text] [Related]
18. Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
Fernandez EV; Reece KM; Ley AM; Troutman SM; Sissung TM; Price DK; Chau CH; Figg WD
Mol Pharmacol; 2015 Jun; 87(6):1006-12. PubMed ID: 25829060
[TBL] [Abstract][Full Text] [Related]
19. Cell type-specific association of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein accumulation and radiobiologic tumor hypoxia.
Vordermark D; Katzer A; Baier K; Kraft P; Flentje M
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1242-50. PubMed ID: 15001269
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
